AKT1 and epilepsy: In the current study, (-) pseudosemiglabrin increased Bcl-2 level, PI3K, and Akt mRNA expression while decreasing Bax, caspase-3, and the Bax/Bcl-2 ratio in a mouse model of pilocarpine-induced epilepsy.